Development and Validation of an Immune-Related Prognostic Signature for Ovarian Cancer Based on Weighted Gene Coexpression Network Analysis

Figure 2

Identification of a prognostic signature in ovarian cancer patients. (a) The high-risk group showed unfavorable overall survival (OS) for ovarian cancer patients using the Kaplan-Meier method. (b) The receiver operating curve (ROC) 3-year OS analysis looking at the signature with other clinical factors using survival ROC in R package. (c) The ROC 3-year OS analysis looking at the signature with the CA-125 gene using survival ROC in R package. (d) A prognostic nomogram of ovarian cancer patients combined the signature and clinical parameters. (e) Correlations between the signature and clinical factors of ovarian cancer patients using one-way ANOVA.

(a)

(b)

(c)

(d)

(e)